NCT05727059 - Magenta Elevate™ EFS in High-Risk PCI Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

January 2, 2024

Conditions

High-risk Percutaneous Coronary Intervention

Interventions

DEVICE

The Elevate™ System

The Magenta Elevate™ is a temporary (≤ 6 hours) ventricular support device indicated for use during high-risk percutaneous coronary interventions (PCI) performed electively or urgently in hemodynamically stable patients, with severe coronary artery disease.

Trial Locations (2)

10029

Mount Sinai Hospital, New York

10032

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York